The global digital diabetes management market was valued at US$ 7.60 Bn in 2022 and is forecast to reach a value of US$ 38.55 Bn by 2030 at a CAGR of 22.5% between 2023 and 2030Key TakeawaysKey players operating in the Digital Diabetes Management are Abbott Laboratories, Acon Laboratories, Inc., Bayer AG, F. Hoffmann-la Roche Ltd., Johnson and...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian